News from Zyme and the companies we work with.
FairJourney Biologics appoints Dr. Werner Lanthaler as Chief Executive Officer
Dr. Werner Lanthaler will strengthen FairJourney Biologics’ global position as a highly efficient partner for antibody discovery and development Founder António Parada will focus on innovation strategy on the Supervisory [...]
SPT Labtech and Agilent Introduce Automated Target Enrichment Protocols for Genomic Workflows
Optimized, automated protocols on SPT Labtech’s firefly®+ using Agilent’s SureSelect Max DNA Library Prep Kit Supports high-throughput sequencing in clinical research, oncology, and precision medicine Protocols to be showcased at [...]
Owlstone Medical Wins up to $49.1 Million Award from ARPA-H to Develop At-home Multi-Cancer-Early Detection Tests
Goal of POSEIDON is to enable accurate, low-cost, accessible cancer screening for all Americans Program to deliver first-in-class synthetic-sensor based MCED test for Stage I detection of 30+ solid tumors [...]
Bio-Rad Extends Partnership with Gencurix Through Strategic Agreement for Droplet Digital™ PCR IVD Oncology Kits in Europe
Extended Partnership Agreement Will Expand Availability Across Europe of Gencurix’ In Vitro Diagnostic (IVD) Assays Using Droplet Digital™ PCR (ddPCR™) for Clinical Testing of Critical Oncology Biomarkers HERCULES, Calif. & [...]
Five Leading Life Science Organisations Collaborate on Inaugural London Bio-Innovation Week
ELRIG, Life Science Integrates, Life Science Nation, One Nucleus and SLAS will provide delegates with the opportunity for cross-event partnering during London Bio-Innovation week, which runs 1st-5th December, 2025 One [...]
Tagomics publishes a new approach to genome-wide epigenomic profiling
Study published in ‘Cell Reports Methods’ demonstrates the strength of Tagomics’ platform for epigenomic biomarker discovery and applications in liquid biopsy Activace platform enables targeted, genome-wide profiling of unmethylated DNA [...]
Miebach Consulting doubles footprint on Abingdon Science Park
Bespoke facilities within The Science Quadrant offer additional capacity as part of ongoing growth Oxford, UK, 25 September 2025: Miebach Consulting (“Miebach”), the strategic supply chain partner for global markets, [...]
SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies
First commercially available NK (natural killer) cell-specific promoter library enables precise and controllable gene expression Portfolio of synthetic promoters validates SynGenSys’ platform for engineering targeted, tissue-specific gene regulation control elements [...]
Atelerix signs agreement with CliniSciences to broaden access to cryo-free preservation solutions across Europe and North Africa
Agreement with specialist life science and diagnostic labs distributor expands global operational reach and market penetration New distribution channels to improve access to Atelerix’s non-cryogenic cell preservation solutions and strengthen [...]
TRIMTECH Therapeutics named as one of Fierce Biotech’s ‘Fierce 15’ for 2025
Fierce 15 highlights pre-commercial biotech companies driving the next generation of therapies for patients worldwide Cambridge, UK, 22 September 2025: TRIMTECH Therapeutics, a biotech company creating novel, small molecule therapeutics [...]
Closed Loop Medicine Launches First Personalized GLP-1 Dosing Platform in U.S.
WeDosify becomes CLM’s first commercially available product – delivering data-driven, adaptive dosing recommendations to improve GLP-1 adherence. Informed by 29 studies and 15,000+ patient profiles; developed to tailor GLP-1 titration [...]
Enhanced Genomics extends Series A funding to USD $19 million to drive development of therapeutics pipeline
Enhanced’s 3D multi-omics platform delivers genetically validated targets for common diseases, accelerating development and increases rates of success in high-value indications Funding from BGF, Parkwalk and Meltwind to drive therapeutics [...]
